0002065545-25-000001.txt : 20250502 0002065545-25-000001.hdr.sgml : 20250502 20250502103307 ACCESSION NUMBER: 0002065545-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20250502 DATE AS OF CHANGE: 20250502 EFFECTIVENESS DATE: 20250502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Salve Therapeutics, Inc. CENTRAL INDEX KEY: 0002065545 ORGANIZATION NAME: EIN: 874619504 STATE OF INCORPORATION: DE FISCAL YEAR END: 1225 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-545076 FILM NUMBER: 25906137 BUSINESS ADDRESS: STREET 1: 461 W 6TH ST STREET 2: SUITE 201 CITY: SAN PEDRO STATE: CA ZIP: 90731 BUSINESS PHONE: 6178944338 MAIL ADDRESS: STREET 1: 461 W 6TH ST STREET 2: SUITE 201 CITY: SAN PEDRO STATE: CA ZIP: 90731 D 1 primary_doc.xml X0708 D LIVE 0002065545 Salve Therapeutics, Inc. 461 W 6TH ST SUITE 201 SAN PEDRO CA CALIFORNIA 90731 6178944338 DELAWARE None None Corporation true 2022 Stefan Nicholas Lukianov 108 LASALLE AVE FRAMINGHAM MA MASSACHUSETTS 01701-4277 Executive Officer Biotechnology No Revenues 06c false 2024-06-10 true true false 1500 687500 12500 675000 true 2 3 0 0 500 false Salve Therapeutics, Inc. Stefan Nicholas Lukianov Stefan Nicholas Lukianov CEO 2025-05-02